Literature DB >> 31771386

Neuroprotective effects of mitoquinone and oleandrin on Parkinson's disease model in zebrafish.

İsmail Ünal1, Esin Çalışkan-Ak2, Ünsal V Üstündağ3, Perihan S Ateş1, Ahmet A Alturfan4, Meric A Altinoz5, Ilhan Elmaci6, Ebru Emekli-Alturfan1.   

Abstract

Aim: The aim of this study is to investigate the possible protective effects of mitoquinone and oleandrin on rotenone induced Parkinson's disease in zebrafish. Materials and methods: Adult zebrafish were exposed to rotenone and mitoquinone for 30 days. Biochemical parameters were determined by spectrophotometric method and Parkinson's disease-related gene expressions were determined by reverse transcription polymerase chain reaction method. Measurement of neurotransmitters was performed by liquid chromatography tandem-mass spectrometry instrument. The accumulation of synuclein was demonstrated by immunohistochemical staining. In vitro thiazolyl blue tetrazolium bromide method was applied to determine the mitochondrial function of synaptosomal brain fractions using rotenone as a neurotoxic agent and mitoquinone and oleandrin as neuroprotective agents.
Results: Mitoquinone improved the oxidant-antioxidant balance and neurotransmitter levels that were disrupted by rotenone. Mitoquinone also ameliorated the expressions of Parkinson's disease-related gene expressions that were disrupted by rotenone. According to thiazolyl blue tetrazolium bromide assay results, mitoquinone and oleandrin increased mitochondrial function which was decreased due to rotenone exposure.
Conclusion: Based on the results of our study, positive effects of mitoquinone were observed in Parkinson's disease model induced by rotenone in zebrafish.

Entities:  

Keywords:  Parkinson’s disease; Zebrafish; mitoquinone; oleandrin

Year:  2019        PMID: 31771386     DOI: 10.1080/00207454.2019.1698567

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

Review 1.  Secondary Mechanisms of Neurotrauma: A Closer Look at the Evidence.

Authors:  Sina Aghili-Mehrizi; Eric Williams; Sandra Yan; Matthew Willman; Jonathan Willman; Brandon Lucke-Wold
Journal:  Diseases       Date:  2022-05-23

Review 2.  Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Manuel Munuera-Cabeza; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; José A Sánchez-Alcázar
Journal:  Antioxidants (Basel)       Date:  2021-02-04

Review 3.  The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment.

Authors:  Khairiah Razali; Noratikah Othman; Mohd Hamzah Mohd Nasir; Abd Almonem Doolaanea; Jaya Kumar; Wisam Nabeel Ibrahim; Norlinah Mohamed Ibrahim; Wael M Y Mohamed
Journal:  Front Genet       Date:  2021-04-15       Impact factor: 4.599

4.  Assessing Anti-Social and Aggressive Behavior in a Zebrafish (Danio rerio) Model of Parkinson's Disease Chronically Exposed to Rotenone.

Authors:  Ovidiu-Dumitru Ilie; Raluca Duta; Roxana Jijie; Ilinca-Bianca Nita; Mircea Nicoara; Caterina Faggio; Romeo Dobrin; Ioannis Mavroudis; Alin Ciobica; Bogdan Doroftei
Journal:  Brain Sci       Date:  2022-07-08

5.  Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish.

Authors:  Derya Cansız; İsmail Ünal; Ünsal Veli Üstündağ; Ahmet Ata Alturfan; Meriç A Altinoz; İlhan Elmacı; Ebru Emekli-Alturfan
Journal:  Mol Biol Rep       Date:  2021-07-06       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.